https://www.openbell.ai/ 2026-11-04T12:30:46.654Z hourly 1.0 https://www.openbell.ai/support 2026-11-04T12:30:46.654Z monthly 0.7 https://www.openbell.ai/privacy 2026-11-04T12:30:46.654Z monthly 0.5 https://www.openbell.ai/terms 2026-11-04T12:30:46.654Z monthly 0.5 https://www.openbell.ai/feed.json 2026-11-04T12:30:46.654Z hourly 0.8 https://www.openbell.ai/news/CCU:1793793704000 2026-11-04T12:01:44.000Z daily 0.9 https://cdn.brandfetch.io/CCU/w/400/h/400?c=1idopYfmtR7ZKg8QMud Compañía Cervecerías Unidas S.A. Reports 3Q26 Financial Results Compañía Cervecerías Unidas (CCU) reported that third-quarter 2026 sales rose 15.5% and EBITDA increased 13.4%; EBITDA growth was 21.3% excluding restructuring expenses. Strength in its Chilean and international businesses was partly offset by weakness in the wine segment. Despite the quarterly gains, year-to-date attributable net income declined 20.4%. https://www.openbell.ai/news/NICE:1793793701000 2026-11-04T12:01:41.000Z daily 0.9 https://cdn.brandfetch.io/NICE/w/400/h/400?c=1idopYfmtR7ZKg8QMud NICE Ltd. Reports Q3 2026 Financial Results and Announces Workforce Reduction NICE Ltd. reported third-quarter 2026 revenue of $790.7 million, up 8% year over year, while AI annual recurring revenue rose 46% to $392 million. The company announced a strategic operating-model streamlining that includes reducing its workforce by approximately 5%. NICE also raised its full-year 2026 earnings-per-share guidance, citing confidence in its efficiency strategy. https://www.openbell.ai/news/CAMT:1793793692000 2026-11-04T12:01:32.000Z daily 0.9 https://cdn.brandfetch.io/CAMT/w/400/h/400?c=1idopYfmtR7ZKg8QMud Camtek Reports Record Third Quarter 2026 Financial Results Camtek reported record third-quarter 2026 revenue of $161.3 million, up 21% quarter over quarter, with GAAP net income of $42.8 million and non-GAAP net income of $50.3 million, or $0.99 per diluted share. Operating cash flow was $71.1 million. The company reiterated fourth-quarter revenue guidance of about $180 million, implying approximately $595 million for full-year 2026, and reaffirmed its initial 2027 revenue outlook of more than $800 million, citing demand for inspection and metrology systems in AI-driven advanced packaging. https://www.openbell.ai/news/LND:1793793686000 2026-11-04T12:01:26.000Z daily 0.9 https://cdn.brandfetch.io/LND/w/400/h/400?c=1idopYfmtR7ZKg8QMud BrasilAgro Reports Earnings Rebound Driven by Farm Monetization BrasilAgro reported net income of R$81.3 million, while total Adjusted EBITDA rose 47%, mainly due to gains from selling the Rio do Meio farm. Agricultural operating Adjusted EBITDA fell 32%. The company’s adjusted net debt-to-LTM Adjusted EBITDA ratio improved to 1.05x. https://www.openbell.ai/news/MMM:1793791910000 2026-11-04T11:31:50.000Z daily 0.9 https://cdn.brandfetch.io/MMM/w/400/h/400?c=1idopYfmtR7ZKg8QMud 3M Announces $7.335 Billion Settlement for PFAS-Related Personal Injury Claims 3M announced a settlement of approximately $7.335 billion to resolve PFAS-related personal injury claims from up to 120,000 plaintiffs alleging health effects from exposure. The company expects to record a $5.8 billion pre-tax charge in the fourth quarter but said it will not affect previously issued financial guidance. 3M did not admit liability and said it remains prepared to defend ongoing litigation. https://www.openbell.ai/news/BMY:1793791900000 2026-11-04T11:31:40.000Z daily 0.9 https://cdn.brandfetch.io/BMY/w/400/h/400?c=1idopYfmtR7ZKg8QMud Bristol Myers Squibb and SystImmune Report Positive Phase 3 Results for Iza-Bren in Breast Cancer Bristol Myers Squibb and SystImmune reported that the Phase 3 PANKU-Breast01 trial met its primary endpoint in patients with HR+/HER2- advanced breast cancer. Izalontamab brengitecan (iza-bren) reduced the risk of disease progression or death by 59% versus chemotherapy, with median progression-free survival of 8.2 months compared with 4.0 months. The confirmed objective response rate was 40.5% with iza-bren versus 20.2% with chemotherapy. Results were presented at the ESMO 2026 Annual Congress and published in The Lancet; the article did not report financial results or a stock-price impact. https://www.openbell.ai/news/LRE:1793791899000 2026-11-04T11:31:39.000Z daily 0.9 https://cdn.brandfetch.io/LRE/w/400/h/400?c=1idopYfmtR7ZKg8QMud Lancashire Holdings Limited Reports Strong 9M 2026 Performance and Declares Special Dividend Lancashire Holdings reported strong performance for the first nine months of 2026 and said it expects a high-teens return on equity for the full year. The company declared a $182 million special dividend. Management expects a more competitive, softening market in 2027, while planning to maintain disciplined underwriting and expand selectively in certain product lines. https://www.openbell.ai/news/ORCL:1793791898000 2026-11-04T11:31:38.000Z daily 0.9 https://cdn.brandfetch.io/ORCL/w/400/h/400?c=1idopYfmtR7ZKg8QMud Oracle Cancels $7 Billion Chip-Leasing Deal with Tencent Oracle canceled a chip-leasing deal with Tencent valued at about $7 billion, which would have provided access to roughly 100,000 advanced AI chips in Southeast Asian data centers over five years. The companies had not formally announced the agreement. The cancellation followed reported concerns from U.S. officials and pressure on Tencent from Chinese authorities to favor domestic technology, underscoring rising regulatory and geopolitical risks for U.S. cloud providers serving Chinese AI companies. https://www.openbell.ai/news/AMGN:1793791895000 2026-11-04T11:31:35.000Z daily 0.9 https://cdn.brandfetch.io/AMGN/w/400/h/400?c=1idopYfmtR7ZKg8QMud Amgen Announces Positive Phase 3 Clinical Results and FDA Labeling Update Amgen reported that its Phase 3 OASIZ-301 study of dazodalibep met its primary endpoint, significantly improving Sjögren’s disease symptoms at Week 48; full results are expected at an upcoming industry conference. Its Phase 3 TEPEZZA study in Japanese patients with chronic thyroid eye disease met both primary endpoints, with a safety profile consistent with established data. The FDA also approved updated IMDELLTRA labeling that shortens monitoring after the first two doses from 22–24 hours to 6–8 hours in appropriate healthcare settings. The article did not report financial results or stock-price movements. https://www.openbell.ai/news/BGEO:1793786541000 2026-11-04T10:02:21.000Z daily 0.9 https://cdn.brandfetch.io/BGEO/w/400/h/400?c=1idopYfmtR7ZKg8QMud Lion Finance Group Reports Higher Q3 Attributable Profit and Net Operating Income Lion Finance Group reported third-quarter attributable profit of 661.9 million Georgian Lari, up from 547.2 million GEL a year earlier. Net operating income also increased, though the company did not provide a figure for the growth. The results cover the three months ending in 2026. https://www.openbell.ai/news/NVO:1793786516000 2026-11-04T10:01:56.000Z daily 0.9 https://cdn.brandfetch.io/NVO/w/400/h/400?c=1idopYfmtR7ZKg8QMud Novo Nordisk Reports Q3 2026 Results and Raises Full-Year Guidance Novo Nordisk reported third-quarter 2026 sales of 79.19 billion Danish kroner, up 6% year over year, with the recently launched Wegovy pill contributing 5.39 billion kroner. Citing strong uptake of its GLP-1 products, the company raised its full-year 2026 guidance for sales and adjusted operating profit growth to -2% to 2% at constant exchange rates, an improvement of about three percentage points from its previous outlook. https://www.openbell.ai/news/CHT:1793786507000 2026-11-04T10:01:47.000Z daily 0.9 https://cdn.brandfetch.io/CHT/w/400/h/400?c=1idopYfmtR7ZKg8QMud Chunghwa Telecom Reports Un-Audited Consolidated Operating Results for the Third Quarter of 2026 Chunghwa Telecom reported unaudited third-quarter 2026 revenue of NT$67.59 billion, up 16.7% year over year and above the high end of its guidance. Revenue, profit and earnings per share reached their highest third-quarter levels since 2009, supported by 6.3% growth in the Consumer Business Group, 8.2% growth in the Enterprise Business Group on strong ICT performance, and a one-off gain from asset revitalization. Management said it remains confident of meeting its full-year guidance. https://www.openbell.ai/news/MKS:1793784730000 2026-11-04T09:32:10.000Z daily 0.9 https://cdn.brandfetch.io/MKS/w/400/h/400?c=1idopYfmtR7ZKg8QMud Marks & Spencer Announces Interim Results for 26 Weeks Ended 26 September 2026 Marks & Spencer reported interim results for the 26 weeks ended 26 September 2026, with food sales up 13.9% year over year and UK market-share gains. Sales in Fashion, Home & Beauty rose 17.5%. The company also reported a rebound in profit performance, but the article provided no specific profit figures or stock-market reaction. https://www.openbell.ai/news/GL9:1793784724000 2026-11-04T09:32:04.000Z daily 0.9 https://cdn.brandfetch.io/GL9/w/400/h/400?c=1idopYfmtR7ZKg8QMud Glanbia Raises FY2026 Adjusted EPS Growth Guidance Glanbia reported a 9.9% increase in like-for-like revenue for the nine months ended October 3, 2026, driven by 4.2% volume growth and a 5.7% rise in pricing. Based on the performance, it raised its full-year 2026 adjusted EPS growth guidance to 22%–24%. https://www.openbell.ai/news/700:1793784707000 2026-11-04T09:31:47.000Z daily 0.9 https://cdn.brandfetch.io/700/w/400/h/400?c=1idopYfmtR7ZKg8QMud Oracle Cancels $7 Billion AI Chip-Leasing Deal with Tencent Oracle canceled a reported five-year, $7 billion deal to provide Tencent access to about 100,000 advanced AI chips in Southeast Asian data centers. The cancellation reportedly followed U.S. administration pressure over supplying advanced AI technology to Chinese companies, limiting Tencent’s access to the hardware for overseas operations and underscoring regulatory tensions for U.S. cloud providers serving Chinese AI firms. https://www.openbell.ai/news/A5G:1793784691000 2026-11-04T09:31:31.000Z daily 0.9 https://cdn.brandfetch.io/A5G/w/400/h/400?c=1idopYfmtR7ZKg8QMud AIB Group Reports Nine-Month Financial Results and Upgrades FY26 Guidance AIB Group reported nine-month net interest income of €2.87 billion, up 2% year over year, while total income increased 3%; third-quarter net interest income was €1.0 billion. The bank raised its FY2026 net interest income guidance to above €3.85 billion from above €3.8 billion, citing performance supported primarily by higher average volumes. AIB said its search for a new CFO is well advanced and plans to outline its strategy through 2030 alongside its 2026 annual results in March 2027. https://www.openbell.ai/news/TUNE:1793782917000 2026-11-04T09:01:57.000Z daily 0.9 https://cdn.brandfetch.io/TUNE/w/400/h/400?c=1idopYfmtR7ZKg8QMud Focusrite plc Announces Interim Results for the Six Months Ended 31 August 2026 Focusrite reported revenue of £90.3 million for the six months ended 31 August 2026, up 2.7% as reported and 2.5% organically, with a gross margin of 46.6%. Adjusted EBITDA rose 10.9% to £15.8 million, adjusted operating profit increased 14.7% to £11.1 million, and adjusted diluted EPS grew 25.5% to 12.8p, partly helped by a £2.4 million US tariff refund. Net debt improved by £9.3 million to a net cash position of £1.5 million, and the company raised its interim dividend 3% to 2.16p. Focusrite cited product-development and operational-efficiency investments and scheduled a Capital Markets Event for 25 November 2026. https://www.openbell.ai/news/MTRO:1793782916000 2026-11-04T09:01:56.000Z daily 0.9 https://cdn.brandfetch.io/MTRO/w/400/h/400?c=1idopYfmtR7ZKg8QMud Metro Bank Holdings PLC Reports Third Quarter 2026 Trading Update Metro Bank reported 37% year-on-year growth in target lending segments in Q3 2026, including corporate, commercial, SME and specialist mortgage lending. Structural net interest margin expanded by 42 basis points to 3.45%, reaching the bank’s full-year guidance range. Customer deposits totaled £13.0 billion, with a net loan-to-deposit ratio of 71%. Management reaffirmed its existing guidance for the rest of the year, citing underlying momentum and operating leverage. https://www.openbell.ai/news/MPAL:1793782912000 2026-11-04T09:01:52.000Z daily 0.9 https://cdn.brandfetch.io/MPAL/w/400/h/400?c=1idopYfmtR7ZKg8QMud MedPal AI plc Announces October 2026 Trading Update MedPal AI reported unaudited October 2026 group revenue of approximately £4.1 million, up from £3.2 million in September. Its New Health division generated £3.63 million, a 33% month-on-month increase, with more than 29,400 orders. Repeat-order revenue more than doubled to £1.34 million, or 37% of the division’s revenue, and has grown more than thirteen-fold since August. Group recurring revenue was approximately £1.8 million, equal to 45% of total revenue, supporting a pro forma annualised run-rate of £49 million. https://www.openbell.ai/news/ORC.A:1793782911000 2026-11-04T09:01:51.000Z daily 0.9 https://cdn.brandfetch.io/ORC.A/w/400/h/400?c=1idopYfmtR7ZKg8QMud Orca Energy Group Inc. Announces Special Meeting to Consider Liquidation and Delisting Orca Energy Group Inc. mailed shareholders a management information circular for a special meeting on November 24, 2026. Shareholders will vote on a non-binding proposal authorizing the board to plan a voluntary liquidation and on a proposal to delist the company’s shares from the TSX Venture Exchange. The board will determine the timing, with delisting expected before June 30, 2027. https://www.openbell.ai/news/GSM:1793782886000 2026-11-04T09:01:26.000Z daily 0.9 https://cdn.brandfetch.io/GSM/w/400/h/400?c=1idopYfmtR7ZKg8QMud Ferroglobe Reports Third Quarter 2026 Financial Results and Announces Profitability Improvement Plan Ferroglobe reported Q3 2026 sales of $369.8 million, down 2.3% sequentially but up 18.6% year over year, and adjusted EBITDA of negative $2.4 million. The company attributed the loss primarily to higher energy costs linked to the Middle East conflict and excess ferrosilicon imports into Europe. Its profitability plan includes closing five plants and cutting overhead costs by 20%, targeting $85 million to $115 million in adjusted EBITDA improvement at full run rate. Chief Legal Officer and Group Company Secretary Thomas Wiesner will step down effective November 4, 2026. https://www.openbell.ai/news/BARN:1793781151000 2026-11-04T08:32:31.000Z daily 0.9 https://cdn.brandfetch.io/BARN/w/400/h/400?c=1idopYfmtR7ZKg8QMud Barry Callebaut Revises Profit Forecast Downward Amid Rising Cocoa Prices Barry Callebaut lowered its profit forecast, citing an expected rise in cocoa prices. The company said the revision reflects changing conditions in the cocoa market; the article provides no specific financial figures or stock-price impact. https://www.openbell.ai/news/TX:1793781136000 2026-11-04T08:32:16.000Z daily 0.9 https://cdn.brandfetch.io/TX/w/400/h/400?c=1idopYfmtR7ZKg8QMud Ternium Returns to Profitability in Third Quarter Ternium S.A. reported a return to profitability in the third quarter, improving its financial performance from previous periods. The Latin American steel producer attributed the results to its operations and market conditions, but the report provided no specific revenue, profit, or growth figures.